NCT03346434 · Interventional trial
Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to <6 Years With Moderate-to-Severe Atopic Dermatitis (Liberty AD PRESCHOOL)
Overall registry status Completed
Phase 2 · Phase 3
Conditions Dermatitis, Atopic
Delaware Valley sites
- Regeneron Investigational Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory